XM does not provide services to residents of the United States of America.
M
M

Marvell

News

U.S. STOCKS Zimmer Biomet, Shake Shack, Microsoft

BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Shake Shack, Microsoft Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes advanced on Wednesday, with the tech-heavy Nasdaq rising to a record high, as investors assessed corporate earnings as well as crucial data showing the economy maintained a steady pace of growth in the third quarter.
A
A
B
C
C
D
E
G
M
M
N
Q
Q
V
A
K
S
U
U
G
W
Z
D
F
O

U.S. STOCKS XPO, Blueprint Medicines, AbbVie

BUZZ-U.S. STOCKS ON THE MOVE-XPO, Blueprint Medicines, AbbVie Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were muted on Wednesday as investors assessed mixed corporate results as well as crucial data showing the economy maintained a steady pace of growth in the third quarter.
A
B
C
C
D
E
M
N
Q
Q
V
A
K
S
U
U
G
W
F
O

US chip stocks down after AMD, QRVO dour forecasts

BUZZ-US chip stocks down after AMD, QRVO dour forecasts Updates ** U.S.-listed chip stocks fall after Advanced Micro Devices AMD.O and chipmaker Qorvo QRVO.O dour forecasts ** AMD on Tuesday forecast Q4 rev. just shy of estimates and raised its AI chip sales forecast to $5 bln for 2025 - not enough to impress i nvestors looking for a bigger windfal
B
I
M
M
N
Q
Q
A
T

US chip stocks fall after AMD's downbeat Q4 revenue forecast

CORRECTED-BUZZ-US chip stocks fall after AMD's downbeat Q4 revenue forecast Corrects bullet 2 to say $5 billion AI chip sales forecast is for 2024, not 2025 ** U.S.-listed chip stocks fall premarket after Advanced Micro Devices AMD.O revenue forecast failed to impress investors looking for a bigger windfall from the AI boom ** AMD on Tuesday forecast Q4 rev.
B
I
M
M
N
Q
A
T

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Arm Holdings PLC ARM.OQ +4.4% Moderna Inc MRNA.OQ +3.3% PDD Holdings Inc PDD.OQ +2.7% NXP Semiconductors NV NXPI.OQ +2.4% Marvell Technology Inc MRVL.OQ +2.3% Bottom Performers Percent Change GE Healthcare Technologies Inc GEHC.OQ -3.2% Diamondback Energy Inc FANG.OQ -3.1% Lam Research Corp LRCX.OQ -2.7% Tesla Inc TSLA.OQ -2.3% Charter Communications Inc CHTR.OQ -1.9% The Nasdaq 1
C
M
N
T
L
U
D
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.